HYAL1 and neoplasm: In colorectal cancer, high expression of HYAL1 and HYAL2 can inhibit tumor metastasis (60), but in triple-negative breast cancer, high expression of HYAL2 genes is associated with shorter disease-free survival, higher tumor recurrence rate, and higher tumor metastasis rate (61).